September 17, 2012

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2012 ACS

Patent Number: WO 2012080220
Title: Method for producing 2-(2-amino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid derivatives
Inventor(s): Griffioen, Gerard; Van Dooren, Tom; Rojas de la Parra, Veronica; Marchand, Arnaud; Allasia, Sara; Kilonda, Amuri; Chaltin, Patrick
Patent Assignee(s): Katholieke Universiteit Leuven, K.U. Leuven R&D, Belg.; Remynd
Source: PCT Int. Appl., 134pp. CODEN: PIXXD2
Language: English

Abstract:

Title compds. I [E independently = CR3 or N; R1, R3, R4 and R6 independently = H, halo, OH, etc.; R2 = H, alkyl, alkenyl or alkynyl; R5 = halo, OH, SH, etc.; n = 1-2; Y1-5 independently = CH, N, NH, etc.; ring B = aryl, cycloalkyl, cycloalkenyl, cycloalkynyl or heterocycle; m = 0-5; each R8 independently = H, halo, alkyl, etc.], and their stereoisomers, enantiomers, tautomers or pharmaceutically acceptable salts, are prepared. Thus, e.g., II was prepared by Suzuki reaction of N-[2-(5-chloro-1H-indol-3-yl)ethyl]-4-iodobenzamide with 4-hydroxyphenylboronic acid.  II inhibited LDH leakage of M17-TAU P301L cells with EC50 value of 7 nM.  The invention compds. are useful as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurol. disorders, such as disorders collectively known as tauopathies, and disorders characterized by cytotoxic alpha-synuclein amyloidogenesis.

Please note:  Abstracts for patent records in CAplus are routinely enhanced to better describe the claimed invention. In this example, CAS enhanced the abstract using additional information found in the patent.

 

View the full-text here.

Recent News


    August 7, 2015 | CAS Announces the 2015 SciFinder
    Future Leaders in Chemistry and First-Ever Alumni
    Program
   
    August 3, 2015 | New STN Breaks Ground with
    Markush Structure Search and Enhanced Content
    for Intellectual Property Exploration and Research
   
    June 29, 2015 | CAS Assigns the 100 Millionth CAS
    Registry Number to a Substance Designed to
    Treat Acute Myeloid Leukemia
   
                                                                       More News >> 
 
 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org